120 likes | 140 Views
The global biosimilar market is evaluated to enlist a CAGR of 40.14% over the conjecture time frame to arrive at a market size of US$19.151 billion by 2023 from US$2.528 billion of every 2017. Market intelligence is introduced as examination, diagrams, and illustrations to help the customers in increasing a quicker and effective comprehension of the global biosimilar market.<br><br>For more information visit here: https://www.knowledge-sourcing.com/report/global-biosimilar-market<br>
E N D
BiosimilarsMarket Forecast From 2019 to 2024
DESCRIPTION As per the latest reports by Knowledge Sourcing Intelligence, The global biosimilar market is estimated to register a CAGR of 40.14% over the forecast period of to reach a market size of US$19.151 billion by 2023 from US$2.528 billion in 2017. Biosimilars are defined as the licensed and highly similar version of biologic drugs that have already been approved for use by the regulatory bodies. The growth in the market may be attributed to the cost-effectiveness of the biosimilars when compared to reference biologics coupled with the patent expiration of the many blockbuster biologic drugs. By 2018, biologics worth more than US$68 billion annual sales will lose patent protection. Estimated patent and exclusivity expiry of few of the blockbuster biologics are given below. Due to structural complexity of the biosimilar drugs, multi-layered manufacturing and risk of immunogenicity, separate regulatory pathways have been drafted to introduce them into the market.
Key Questions Answered By The Report • What will be Biosimilars Marketfrom 2019 to 2024? • How are the major drivers and restraints affecting the Biosimilars Market? • growth and the opportunities which exist for key vendors? • Which segment and region will drive or lead the market growth and why? • A comprehensive analysis of competitive landscape and key market participant’s behavior • Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth
Segments Covered Under Biosimilars Market are : • By Type • Monoclonal antibodies • Recombinant Proteins • Hormones • Others • By Disease • Infectious Disease • Oncology and Immunology • Respiratory • Genetic Disorders • Others
Geography North America USA Canada Mexico Others South America Brazil Argentina Others
Geography Europe Germany France United Kingdom Others Middle East and Africa Saudi Arabia Israel Others
Geography Asia Pacific China Japan India Others
COMPANY PROFILES • Samsung Bioepis • Stada Arzneimittel AG • Sandoz International GmbH (A Novartis Company) • Amgen Inc. • Apotex Inc. • BioCad • Dr. Reddy’s Laboratories Ltd. • Biocon • Boehringer Ingelheim International GmbH • Cinfa Biotech • Biogen International • Hospira (A Pfizer Company)
TO ORDER OR REQUEST FOR A SAMPLE: BiosimilarsMarket– Forecasts from 2019 to 2024 Link : https://www.knowledge-sourcing.com/report/global-biosimilar-market Price: US$3,160 – Single User License US$4,550 – Multi User License US$6,950 – Enterprise License Payment: To pay by Credit Card, please, click “Add to Cart” button on product page and proceed with payment. For wire transfer, write to us at sales@knowledge-sourcing.com For any custom requirements or queries, please visit our website or call us: Website: www.knowledge-sourcing.com Phone: +1-850-250-1698
Contact Us Address Knowledge Sourcing Intelligence LLPSuite 406, BSI Business ParkH-140, Sector 63 Noida, U.P. - 201301India Phone: +1-850-250-1698 Email info@knowledge-sourcing.com Visit us : https://www.knowledge-sourcing.com
Follow Us: Press Releases and Blogs: Click Here…
THANK YOU